Patents by Inventor Satoru Ayano
Satoru Ayano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240093134Abstract: Provided is a culture chamber capable of preparing spheroids with a uniform size with high efficiency and having a micro-space structure which is designed to facilitate replacement of a medium and harvesting of cells. The culture chamber includes a plurality of recesses (10) each formed of a bottom portion (11) and an opening portion (12). The bottom portion (11) has one of a hemispherical shape and a truncated cone shape and the opening portion (12) is defined by a wall that surrounds an area from a boundary between the opening portion (12) and the bottom portion (11) to an end of each of the recesses (10), the wall having a taper angle in a range from 1 degree to 20 degrees. An equivalent diameter of the boundary is in a range from 50 ?m to 2 mm and a depth from a bottom of the bottom portion (11) to the end of each of the recesses is in a range from 0.Type: ApplicationFiled: November 28, 2023Publication date: March 21, 2024Inventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Patent number: 11866682Abstract: Provided is a culture chamber that includes a plurality of recesses each formed of a bottom portion and an opening portion. The bottom portion has a hemispherical shape or a truncated cone shape. The opening portion is defined by a wall that surrounds an area from a boundary between the opening portion and the bottom portion to an end of each of the recesses, the wall having a taper angle in a range from 1 to 20 degrees. An equivalent diameter of the boundary is from 50 ?m to 2 mm and a depth from a bottom of the bottom portion to the end of each of the recesses is from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion forms a surface continuous to the bottom portion. An inclination of the continuous surface changes at the boundary.Type: GrantFiled: September 30, 2022Date of Patent: January 9, 2024Assignee: CORNING INCORPORATEDInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Publication number: 20230414832Abstract: An object of this invention relates to provide a macroencapsulation immunoisolation device that can be easily removed, does not break, and is suitable for improvement in the diffusion efficiency of a physiologically active substance required for transplantation while maintaining an immunoisolation effect. The present invention provide an immunoisolation device comprising an embedding chamber for a material to be transplanted, the embedding chamber being covered with an immunoisolation membrane.Type: ApplicationFiled: October 28, 2021Publication date: December 28, 2023Applicant: KURARAY CO., LTD.Inventors: Goro KOBAYASHI, Masako KAWAGOE, Satoru AYANO
-
Publication number: 20230302204Abstract: An object of this invention is to simultaneously achieve, in long-term transplantation of a macroencapsulation immunoisolation device using a porous membrane or the like, improvement in the diffusion efficiency of physiologically active substances released from a material to be transplanted, improvement in the diffusion efficiency of nutrients to cells and the like, which are the material to be transplanted, and uniform and efficient dispersion and fixation of cells and the like encapsulated as the material to be transplanted in the macroencapsulation immunoisolation device, while maintaining an immunoisolation effect. The present invention provides a hydrogel for embedding a material to be transplanted, comprising a polymer crosslinked by visible light, and water.Type: ApplicationFiled: October 28, 2021Publication date: September 28, 2023Applicant: KURARAY CO., LTD.Inventors: Goro KOBAYASHI, Masako KAWAGOE, Akio FUJITA, Satoru AYANO
-
Patent number: 11473046Abstract: Provided is a culture chamber that includes a plurality of recesses each formed of a bottom portion and an opening portion. The bottom portion has a hemispherical shape or a truncated cone shape. The opening portion is defined by a wall that surrounds an area from a boundary between the opening portion and the bottom portion to an end of each of the recesses, the wall having a taper angle in a range from 1 to 20 degrees. An equivalent diameter of the boundary is from 50 ?m to 2 mm and a depth from a bottom of the bottom portion to the end of each of the recesses is from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion forms a surface continuous to the bottom portion. An inclination of the continuous surface changes at the boundary.Type: GrantFiled: October 30, 2019Date of Patent: October 18, 2022Assignee: CORNING INCORPORATEDInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Patent number: 11060065Abstract: A tissue structure for enabling comprehensive understanding of gene patterns of mature cells and a method of preparing the tissue structure are provided. A tissue structure is obtained by co-culturing an endodermal, ectodermal, or mesodermal cell derived from a stem cell and at least one cell and/or factor selected from the group consisting of a vascular cell, a mesenchymal cell, a factor secreted by a vascular cell, a factor secreted by a mesenchymal cell, and a factor secreted when both a vascular cell and a mesenchymal cell exist. A value obtained by assay of a plurality of functions using a Pearson product-moment correlation coefficient is closer to a value of a cell or biological tissue sampled from an adult than a value of a cell or biological tissue sampled from a fetus.Type: GrantFiled: June 9, 2014Date of Patent: July 13, 2021Assignees: Corning Incorporated, PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITYInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Publication number: 20200256850Abstract: Provided is a technique that uses an established hepatocyte cell line in a method for evaluating an effect of a cytokine on a metabolic activity of a cytochrome P450 and in a method for evaluating a drug which interacts with a cytokine. The method for evaluating an effect of a cytokine on a metabolic activity of a cytochrome P450 includes: culturing an established hepatocyte cell line by using a culture chamber (10) including culture rooms (11), to thereby form spheroids (9); and evaluating the presence or absence of induction or attenuation of the cytochrome P450 after bringing a spheroid-shaped established hepatocyte cell line into contact with a test solution containing the cytokine in the culture chamber for one hour or more and less than 96 hours.Type: ApplicationFiled: April 27, 2020Publication date: August 13, 2020Inventors: Satoru Ayano, Kan Chiba, Yoko Ejiri, Masaya Hosoda, Kaoru Kobayashi, Hanaka Mimura
-
Publication number: 20200239854Abstract: Provided are a method capable of evaluating adherent cells under an environment similar to an in vivo environment by a culture method similar to a two-dimensional culture, and applications thereof. An adherent cell culture method uses, as a culture chamber (10), a chamber in which two or more culture spaces each having an equivalent diameter (D) that is 1 to 5 times the diameter of a desired spheroid and each having a height (H) that is 0.3 to 5 times the equivalent diameter are arranged and a surface of each of the culture spaces has a water contact angle of 45 degrees or less. Spheroids of adherent cells are cultured in the respective culture spaces (11) arranged in the culture chamber (10).Type: ApplicationFiled: April 13, 2020Publication date: July 30, 2020Inventors: Satoru Ayano, Masaya Hosoda, Yoko Ejiri, Go Tazaki
-
Patent number: 10677783Abstract: Provided is a technique that uses an established hepatocyte cell line in a method for evaluating an effect of a cytokine on a metabolic activity of a cytochrome P450 and in a method for evaluating a drug which interacts with a cytokine. The method for evaluating an effect of a cytokine on a metabolic activity of a cytochrome P450 includes: culturing an established hepatocyte cell line by using a culture chamber (10) including culture rooms (11), to thereby form spheroids (9); and evaluating the presence or absence of induction or attenuation of the cytochrome P450 after bringing a spheroid-shaped established hepatocyte cell line into contact with a test solution containing the cytokine in the culture chamber for one hour or more and less than 96 hours.Type: GrantFiled: September 27, 2013Date of Patent: June 9, 2020Assignee: Corning IncorporatedInventors: Kaoru Kobayashi, Hanaka Mimura, Kan Chiba, Yoko Ejiri, Masaya Hosoda, Satoru Ayano
-
Patent number: 10655107Abstract: Provided are a method capable of evaluating adherent cells under an environment similar to an in vivo environment by a culture method similar to a two-dimensional culture, and applications thereof. An adherent cell culture method uses, as a culture chamber (10), a chamber in which two or more culture spaces each having an equivalent diameter (D) that is 1 to 5 times the diameter of a desired spheroid and each having a height (H) that is 0.3 to 5 times the equivalent diameter are arranged and a surface of each of the culture spaces has a water contact angle of 45 degrees or less. Spheroids of adherent cells are cultured in the respective culture spaces (11) arranged in the culture chamber (10).Type: GrantFiled: September 20, 2012Date of Patent: May 19, 2020Assignee: Corning IncorporatedInventors: Yoko Ejiri, Satoru Ayano, Masaya Hosoda, Go Tazaki
-
Publication number: 20200063080Abstract: Provided is a culture chamber that includes a plurality of recesses each formed of a bottom portion and an opening portion. The bottom portion has a hemispherical shape or a truncated cone shape. The opening portion is defined by a wall that surrounds an area from a boundary between the opening portion and the bottom portion to an end of each of the recesses, the wall having a taper angle in a range from 1 to 20 degrees. An equivalent diameter of the boundary is from 50 ?m to 2 mm and a depth from a bottom of the bottom portion to the end of each of the recesses is from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion forms a surface continuous to the bottom portion. An inclination of the continuous surface changes at the boundary.Type: ApplicationFiled: October 30, 2019Publication date: February 27, 2020Applicants: Corning Incorporated, Public University Corporation Yokohama City UniversityInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Patent number: 10494593Abstract: A culture chamber includes a plurality of recesses (10) each formed of a bottom portion (11) and an opening portion (12). The bottom portion (11) has a hemispherical shape and the opening portion (12) is defined by a wall that surrounds an area from a boundary between the opening portion (12) and the bottom portion (11) to an end of each of the recesses (10), the wall having a taper angle in a range from 1 degree to 20 degrees. An equivalent diameter of the boundary is in a range from 50 ?m to 2 mm and a depth from a bottom of the bottom portion (11) to the end of each of the recesses is in a range from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion (12) forms a surface continuous to the bottom portion (11).Type: GrantFiled: June 5, 2014Date of Patent: December 3, 2019Assignees: CORNING INCORPORATED, PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITYInventors: Yoko Ejiri, Satoru Ayano, Naoto Fukuhara, Hideki Taniguchi, Takanori Takebe
-
Publication number: 20160137962Abstract: A culture chamber includes a plurality of recesses (10) each formed of a bottom portion (11) and an opening portion (12). The bottom portion (11) has a hemispherical shape and the opening portion (12) is defined by a wall that surrounds an area from a boundary between the opening portion (12) and the bottom portion (11) to an end of each of the recesses (10), the wall having a taper angle in a range from 1 degree to 20 degrees. An equivalent diameter of the boundary is in a range from 50 ?m to 2 mm and a depth from a bottom of the bottom portion (11) to the end of each of the recesses is in a range from 0.6 or more times to 3 or less times the equivalent diameter, and the wall defining the opening portion (12) forms a surface continuous to the bottom portion (11).Type: ApplicationFiled: June 5, 2014Publication date: May 19, 2016Applicants: KURARAY Co., Ltd., Public University Corporation Yokohama City UniversityInventors: Yoko EJIRI, Satoru AYANO, Naoto FUKUHARA, Hideki TANIGUCHI, Takanori TAKEBE
-
Publication number: 20160122722Abstract: A tissue structure for enabling comprehensive understanding of gene patterns of mature cells and a method of preparing the tissue structure are provided. A tissue structure is obtained by co-culturing an endodermal, ectodermal, or mesodermal cell derived from a stem cell and at least one cell and/or factor selected from the group consisting of a vascular cell, a mesenchymal cell, a factor secreted by a vascular cell, a factor secreted by a mesenchymal cell, and a factor secreted when both a vascular cell and a mesenchymal cell exist. A value obtained by assay of a plurality of functions using a Pearson product-moment correlation coefficient is closer to a value of a cell or biological tissue sampled from an adult than a value of a cell or biological tissue sampled from a fetus.Type: ApplicationFiled: June 9, 2014Publication date: May 5, 2016Applicants: KURARAY Co., Ltd., Public University Corporation Yokohama City UniversityInventors: Yoko EJIRI, Satoru AYANO, Naoto FUKUHARA, Hideki TANIGUCHI, Takanori TAKEBE
-
Publication number: 20150276716Abstract: Provided is a technique that uses an established hepatocyte cell line in a method for evaluating an effect of a cytokine on a metabolic activity of a cytochrome P450 and in a method for evaluating a drug which interacts with a cytokine. The method for evaluating an effect of a cytokine on a metabolic activity of a cytochrome P450 includes: culturing an established hepatocyte cell line by using a culture chamber (10) including culture rooms (11), to thereby form spheroids (9); and evaluating the presence or absence of induction or attenuation of the cytochrome P450 after bringing a spheroid-shaped established hepatocyte cell line into contact with a test solution containing the cytokine in the culture chamber for one hour or more and less than 96 hours.Type: ApplicationFiled: September 27, 2013Publication date: October 1, 2015Applicant: KURARAY Co., Ltd.Inventors: Kaoru Kobayashi, Hanaka Mimura, Kan Chiba, Yoko Ejiri, Masaya Hosoda, Satoru Ayano
-
Publication number: 20140227784Abstract: Provided are a method capable of evaluating adherent cells under an environment similar to an in vivo environment by a culture method similar to a two-dimensional culture, and applications thereof. An adherent cell culture method uses, as a culture chamber (10), a chamber in which two or more culture spaces each having an equivalent diameter (D) that is 1 to 5 times the diameter of a desired spheroid and each having a height (H) that is 0.3 to 5 times the equivalent diameter are arranged and a surface of each of the culture spaces has a water contact angle of 45 degrees or less. Spheroids of adherent cells are cultured in the respective culture spaces (11) arranged in the culture chamber (10).Type: ApplicationFiled: September 20, 2012Publication date: August 14, 2014Applicant: KURARAY Co., Ltd.Inventors: Yoko Ejiri, Satoru Ayano, Masaya Hosoda, Go Tazaki